Pages that link to "Q35820088"
Jump to navigation
Jump to search
The following pages link to Should there be a moratorium on the use of cholesterol lowering drugs? (Q35820088):
Displaying 50 items.
- The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393] (Q24793837) (← links)
- The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst (Q24796000) (← links)
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial (Q28214393) (← links)
- Cholesterol lowering and mortality: the importance of considering initial level of risk (Q28270339) (← links)
- Cholesterol reduction and non-illness mortality: meta-analysis of randomised clinical trials (Q28345598) (← links)
- Statins for primary prevention: at what coronary risk is safety assured? (Q28362569) (← links)
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins (Q29547856) (← links)
- Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial (Q29617817) (← links)
- Interpretation of the evidence for the efficacy and safety of statin therapy (Q30245459) (← links)
- The case of the missing data (Q30757064) (← links)
- Safety profile of atorvastatin-treated patients with low LDL-cholesterol levels (Q33421569) (← links)
- Drug utilisation review and pharmacoeconomics: interaction after parallel development? (Q33560186) (← links)
- Cholesterol reduction in the prevention of coronary heart disease: therapeutic rationale and guidelines. The British Hyperlipidaemia Association (Q33613233) (← links)
- The fact and fiction of lowering cholesterol concentrations in the primary prevention of coronary heart disease (Q33613238) (← links)
- Comparison of appropriateness of cholesterol testing in general practice with the recommendations of national guidelines: an audit of patient records in 20 general practices (Q33692295) (← links)
- Randomised controlled trial in northern England of the effect of a person knowing their own serum cholesterol concentration (Q33702194) (← links)
- Cost effectiveness and equity of a community based cardiovascular disease prevention programme in Norsjö, Sweden (Q33703502) (← links)
- Role of an Ethanolic Extract of Crotalaria juncea L. on High-Fat Diet-Induced Hypercholesterolemia (Q33784430) (← links)
- Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke (Q33815841) (← links)
- The discovery and development of atorvastatin, a potent novel hypolipidemic agent (Q33963546) (← links)
- The association of low serum cholesterol with depression and suicidal behaviours: new hypotheses for the missing link. (Q34146972) (← links)
- Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors (Q34207135) (← links)
- HMG-CoA reductase inhibitors (Q34236671) (← links)
- Basic statistics for clinicians: 3. Assessing the effects of treatment: measures of association (Q34278236) (← links)
- Effect of Erythrina variegata seed extract on hyperlipidemia elicited by high-fat diet in wistar rats (Q34373858) (← links)
- How well tolerated are lipid-lowering drugs? (Q34400638) (← links)
- Use of fibrates and cancer risk: a systematic review and meta-analysis of 17 long-term randomized placebo-controlled trials (Q34428524) (← links)
- Utilization of lipid-lowering drugs in men and women. a reflection of the research evidence? (Q34487161) (← links)
- The rise of cholesterol testing: how much is unnecessary (Q34517289) (← links)
- Statin therapy in the elderly: does it make good clinical and economic sense? (Q35086797) (← links)
- Genetic evaluation for coronary artery disease (Q35179025) (← links)
- Hepatotoxicity of hypolipidemic drugs (Q35184569) (← links)
- How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects (Q35187942) (← links)
- The triglyceride connection in atherosclerosis (Q35466693) (← links)
- Testing for Helicobacter pylori in primary care: trouble in store? (Q35558314) (← links)
- Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial (Q35622529) (← links)
- Fatty acid composition of the diet: impact on serum lipids and atherosclerosis (Q35631548) (← links)
- Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry (Q35639538) (← links)
- Low serum cholesterol concentration and short term mortality from injuries in men and women (Q35822906) (← links)
- Statins and hepatotoxicity: focus on patients with fatty liver (Q36079406) (← links)
- Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence (Q36662341) (← links)
- Clinical guidelines: development, implementation, and effectiveness (Q36679591) (← links)
- Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association (Q36683581) (← links)
- Expanding access to coronary artery bypass surgery: who stands to gain? (Q36816083) (← links)
- Mortality in participants and non-participants of a multifactorial prevention study of cardiovascular diseases: a 28 year follow up of the Helsinki Businessmen Study (Q36824647) (← links)
- Assessing possible hazards of reducing serum cholesterol (Q36884291) (← links)
- Serum cholesterol concentration and mortality from accidents, suicide, and other violent causes (Q36886894) (← links)
- Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration (Q36887008) (← links)
- Prevention of cardiovascular disease (Q36920586) (← links)
- Antihypercholesterolemic and Antioxidative Potential of an Extract of the Plant, Piper betle, and Its Active Constituent, Eugenol, in Triton WR-1339-Induced Hypercholesterolemia in Experimental Rats (Q37552335) (← links)